U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H12N6
Molecular Weight 204.2318
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRIETHYLENEMELAMINE

SMILES

C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4

InChI

InChIKey=IUCJMVBFZDHPDX-UHFFFAOYSA-N
InChI=1S/C9H12N6/c1-2-13(1)7-10-8(14-3-4-14)12-9(11-7)15-5-6-15/h1-6H2

HIDE SMILES / InChI

Molecular Formula C9H12N6
Molecular Weight 204.2318
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

TRIETHYLENEMELAMINE, an aziridine derivative, is an alkylating agent with antineoplastic properties. Formerly it was used in the palliative treatment of the lymphomas and leukemias. Now it is used as a research tool to produce chromosome aberrations and cancers.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Tretamine

Approved Use

Antineoplastic.

Launch Date

-5.04921588E11
Doses

Doses

DosePopulationAdverse events​
5 mg 1 times / day multiple, oral (starting)
Dose: 5 mg, 1 times / day
Route: oral
Route: multiple
Dose: 5 mg, 1 times / day
Sources:
unhealthy, 41 - 70 years
n = 6
Health Status: unhealthy
Condition: POLYCYTHEMIA VERA
Age Group: 41 - 70 years
Sex: M+F
Population Size: 6
Sources:
Disc. AE: Nausea, Vomiting...
AEs leading to
discontinuation/dose reduction:
Nausea (severe, 1 patient)
Vomiting (severe, 1 patient)
Sources:
AEs

AEs

AESignificanceDosePopulation
Nausea severe, 1 patient
Disc. AE
5 mg 1 times / day multiple, oral (starting)
Dose: 5 mg, 1 times / day
Route: oral
Route: multiple
Dose: 5 mg, 1 times / day
Sources:
unhealthy, 41 - 70 years
n = 6
Health Status: unhealthy
Condition: POLYCYTHEMIA VERA
Age Group: 41 - 70 years
Sex: M+F
Population Size: 6
Sources:
Vomiting severe, 1 patient
Disc. AE
5 mg 1 times / day multiple, oral (starting)
Dose: 5 mg, 1 times / day
Route: oral
Route: multiple
Dose: 5 mg, 1 times / day
Sources:
unhealthy, 41 - 70 years
n = 6
Health Status: unhealthy
Condition: POLYCYTHEMIA VERA
Age Group: 41 - 70 years
Sex: M+F
Population Size: 6
Sources:
PubMed

PubMed

TitleDatePubMed
Capture of carbon dioxide by amine-impregnated as-synthesized MCM-41.
2010
A new alkaloid isolated from Abies webbiana leaf.
2010 May
Patents

Patents

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:27:45 UTC 2023
Edited
by admin
on Fri Dec 15 16:27:45 UTC 2023
Record UNII
F7IY6HZG9D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TRIETHYLENEMELAMINE
HSDB   MI  
Common Name English
2,4,6-TRIS(1-AZIRIDINYL)-S-TRIAZINE
Common Name English
2,4,6-TRIS(1-AZIRIDINYL)-S-TRIAZINE [IARC]
Common Name English
Tretamine [WHO-DD]
Common Name English
TRIETHYLENE MELAMINE
Common Name English
2,4,6-TRIS(1-AZIRIDINYL)-1,3,5-TRIAZINE
Systematic Name English
TRIETHYLENEMELAMINE [MI]
Common Name English
TRETAMINE [MART.]
Common Name English
1,3,5-TRIAZINE, 2,4,6-TRIS(1-AZIRIDINYL)-.
Common Name English
2,4,6-TRI(AZIRIDIN-1-YL)-1,3,5-TRIAZINE
Systematic Name English
TRETAMINE
INN   MART.   WHO-DD  
INN  
Official Name English
TRIETHYLENEMELAMINE [HSDB]
Common Name English
tretamine [INN]
Common Name English
NSC-9706
Code English
Classification Tree Code System Code
NCI_THESAURUS C292
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C29858
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
DRUG BANK
DB14031
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
WIKIPEDIA
TRIETHYLENEMELAMINE
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
PUBCHEM
5799
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
CHEBI
27919
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
FDA UNII
F7IY6HZG9D
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
INN
329
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
ChEMBL
CHEMBL502384
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-083-5
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
MERCK INDEX
m11106
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY Merck Index
NSC
9706
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
CAS
51-18-3
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID3026225
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
EVMPD
SUB11243MIG
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
DRUG CENTRAL
2739
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
MESH
D014265
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
HSDB
4000
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
SMS_ID
100000077506
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
ALANWOOD
tretamine
Created by admin on Fri Dec 15 16:27:45 UTC 2023 , Edited by admin on Fri Dec 15 16:27:45 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY